Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 25 Paclitaxel 20 Carboplatin 17 Bevacizumab 12 Specimen Handling 10 Letrozole 10 abemaciclib 7 dostarlimab 6 Taxes 6 Blood Specimen Collection 6 Medroxyprogesterone Acetate 5 Magnetic Resonance Spectroscopy 5 Fulvestrant 5 Drug Therapy 5 Doxorubicin 5 Cisplatin 5 Biopsy 5 olaparib 4 lenvatinib 4 atezolizumab 4 Radiotherapy 4 Progestins 4 Observation 4 Nivolumab 4 Megestrol Acetate 4 Immunoglobulin G 4 Gemcitabine 4 trastuzumab deruxtecan 3 palbociclib 3 X-Rays 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × inavolisib × Clear all

NCT04486352 2026-04-01

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡